NGS

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

NGS
Mar 27, 2025, 08:00 | Blog
OHMX.bio joins BRECISE to revolutionize prostate and bladder cancer diagnostics
OHMX.bio shared a post on LinkedIn: "OHMX.bio joins BRECISE to revolutionize cancer diagnostics OHMX.bio is…
Mar 16, 2025, 11:09 | Science
Umberto Malapelle: Costs of biomarker testing in advanced non-small cell lung cancer
Umberto Malapelle, Associate Professor at the School of Medicine at the University of Naples Federico,…
Jan 18, 2025, 22:56 | Blog
Herbert Loong: Philip Ip kicked off the 12th Hong Kong pathology forum
Herbert Loong, Chair of the International Affairs Committee of ASCO, shared a post on X:…
Jan 11, 2025, 17:09 | Science
Biomarker testing in lung cancer: from bench to bedside
Brittney Abernathy, Journal Manager at Frontiers, shared a recent article by Ullas Batra on LinkedIn:…
Dec 30, 2024, 07:41 | Blog
Antonio M. Grimaldi: Next Generation Sequencing diagnostics will soon be available at San Giovanni Addolorata Hospital, Benevento
Antonio M. Grimaldi, Director of U.O.C. Oncology at AORN San Pio, shared a post on…
Dec 16, 2024, 19:07 | Insight
Julie Hallet: Guidance on biomarkers gene therapy for NETs
Julie Hallet, Assistant Professor of Surgery at the University of Toronto, shared a post on…
Dec 12, 2024, 16:24 | Blog
What is NGS and is it suitable for all cancer patients - National Cancer Centre Singapore
National Cancer Centre Singapore shared a post on LinkedIn: “What is next-generation sequencing (NGS) and…
Nov 20, 2024, 11:30 | Insight
Flora Xydaki: Biomarkers in Oncology - Transforming Cancer Diagnosis and Treatment
Flora Xydaki, Project Associate at BTHT, shared a post on LinkedIn: "Biomarkers in Oncology: Transforming Cancer…
Nov 14, 2024, 09:26 | Blog
Christopher Wee: Advocating for faster cancer testing
Christopher Wee, Genitourinary Medical Oncologist at Cleveland Clinic, posted the following on X: “Proud to lend…
Oct 6, 2024, 06:41 | Blog
Min-Han Tan: The era of liquid biopsy is truly emerging and moving beyond blood
Min-Han Tan, Founding CEO at Lucence, shared a post by Lucence on LinkedIn, adding the…
Sep 22, 2024, 09:44 | Insight
Myeloma Paper of the Day, September 22nd, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Optical genome mapping in conjunction with…
Aug 12, 2024, 12:31 | Insight
Rasha Aboelhassan: Why should we test NGS for all lung cancer patients as early as possible
Rasha Aboelhassan shared a post on LinkedIn: "For decades, advance lung cancer was known as…
Aug 9, 2024, 07:05 | Blog
Molecular differences in early-onset biliary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, posted on X about…
Aug 8, 2024, 15:02 | Insight
Myeloma Paper of the Day, August 8th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Single center study confirms achieving…
Aug 6, 2024, 11:29 | Insight
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers
Lung-MAP shared on LinkedIn: "Just out in Journal of Thoracic Oncology (JTO): Lung-MAP Next Generation…
Jul 18, 2024, 08:37 | Blog
Advancing Patient Access to NGS for cancer in APAC
Roche Diagnostics Asia Pacific posted on LinkedIn: "Did you know that clinical outcomes for cancer…
Jul 13, 2024, 16:11 | Blog
Jacob Adashek: Bridging knowledge for advocacy
Jacob Adashek posted on LinkedIn: "Watch our St. Elizabeth Healthcare Dr. Matthew Kurian, MD series…
Jul 11, 2024, 06:14 | Insight
Raffaella Casolino and Joaquin Mateo's report: Our practical tips on how to interpret genomic tests results
Raffaella Casolino, Technical Officer at World Health Organization, shared on X: "Very important piece from ESMO…
Jul 5, 2024, 14:55 | Insight
Insurance Coverage for Next Generation Sequencing and Closing Points - GRACE
Global Resource for Advancing Cancer Education (GRACE) shared on LinkedIn:  “Cancer Genetics 101: Insurance Coverage…
Jun 24, 2024, 02:19 | Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X:                   . "Delighted…
Jun 23, 2024, 17:29 | Insight
Carolina Belmar López: ESMO updates the recommendations for NGS with advanced cancers
Carolina Belmar López, Laboratory Director of Oncogenomics, shared on LinkedIn: . "ESMO updates the recommendations…
Jun 20, 2024, 01:53 | Insight
Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…
Jun 10, 2024, 07:18 | Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
May 14, 2024, 07:15 | Blog
Andrea Necchi: Optimizing the use of NGS in pts with urothelial carcinoma
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X: “Optimizing the use…
May 14, 2024, 02:29 | Blog
Shilpa Gupta: Honored to be panel member for this highly productive San Raffaele Hospital retreat with esteemed experts!
Shilpa Gupta, Director GU Oncology at Cleveland Clinic MD, shared a post by Andrea Necchi, Associate Professor…
May 2, 2024, 23:45 | Insight
Aakash Desai: Insights into mNSCLC Management through a Global Clinician Survey
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post on…
Apr 21, 2024, 17:24 | Insight
Piotr Wysocki: Only biliary tract and ovarian advanced cancer patients seem to benefit from next-generation sequencing
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Jul 18, 2023, 19:54 | Stories
Time to do NGS on all cancers, and study every cancer molecularly/genetically - Sucharu Prakash
It is time! Time to do NGS on all cancers, and study every cancer molecularly/genetically.…
May 14, 2023, 17:22 | Career
Regina Nagle appointed as SVP of Business Development at C2i Genomics - Asaf Zviran
In a post by Asaf Zviran on LinkedIn, it says, "As we continue our strong…
All: 29 Posts: 1 - 100
Special Coverage